• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 82 of 100
Production At The Merck KGaA Pharmaceutical Plant
HealthChina suspends Ali Health-run online drug monitoring platform
By ReutersFebruary 21, 2016
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
LeadershipSeveral Witnesses in the Martin Shkreli Case Are Worried About Retaliation
By ReutersFebruary 19, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthThese Philanthropists Just Gave $7.2 Million to Solve the Drug Price Crisis
By Laura LorenzettiFebruary 17, 2016
Daily Antiretroviral Pill Found To Protect Healthy From AIDS Transmission
HealthExpress Scripts Won’t Air ‘Dirty Laundry’ In Heated Anthem Dispute
By Laura LorenzettiFebruary 17, 2016
AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms
HealthSome Popular Heartburn Drugs Have Been Linked to Dementia
By Claire GrodenFebruary 16, 2016
Donald Trump Campaigns In New Hampshire Ahead Of Primary
HealthTrump Somehow Plans to Negotiate Drug Prices to Zero
By Laura LorenzettiFebruary 12, 2016
BRITAIN-PHARMACEUTICAL-GSK
HealthGlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
By Laura LorenzettiFebruary 12, 2016
House Oversight Hearing On Prescription Drug Price Increases
Arts & EntertainmentMartin Shkreli Just Offered Kanye West $10 Million For His New Album
By Ben GeierFebruary 11, 2016
Fortune Global Forum 2015
LeadershipTheranos May Lose Its Biggest Blood-Testing Customer
By ReutersFebruary 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
Medical Records Archive - IMS Health
HealthThis Little-Known Firm Is Getting Rich Off Your Medical Data
By Adam TannerFebruary 9, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthU.S. Is Probing a Possible Half-Billion Dollar Health-Care Fraud
By Michal AddadyFebruary 7, 2016
132093105
MPWDear Biopharma Bros, Stop Treating Women Like ‘Chattel’
By Valentina ZaryaFebruary 5, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
HealthMartin Shkreli Calls U.S. Lawmakers ‘Imbeciles’
By Laura LorenzettiFebruary 4, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthHow Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
1...
  • 80
  • 81
  • 82
  • 83
  • 84
...100
Most Popular
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.